Open-label Leucovorin Pharmacokinetic Study in Patients Receiving High Dose Methotrexate With or Without Voraxaze
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate whether the administration of Voraxaze reduces
exposure to leucovorin and its active metabolite to below the level achieved in patients who
have not received Voraxaze.